Clinical trial
Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease
NCT00876863
Study timeline
Study start (actual)2008-11-01Date precision: month
Registry last updated2020-12-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer's Diseaseunresolved
Interventions
Sponsors & collaborators
Sangamo Therapeuticslead sponsor
Alzheimer's Disease Cooperative Study (ADCS)collaborator
Mapped research locations
New YorkNew York, United States1Los AngelesCalifornia, United States1AtlantaGeorgia, United States1ClevelandOhio, United States1BirminghamAlabama, United States1San DiegoCalifornia, United States1DurhamNorth Carolina, United States1Washington D.C.District of Columbia, United States1Salt Lake CityUtah, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00876863 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.